ClinicalTrials.gov record
No Longer Available No phase listed Expanded access

Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver

ClinicalTrials.gov ID: NCT01728051

Public ClinicalTrials.gov record NCT01728051. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 11:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label, Expanded Access Study of Melphalan Chemosaturation With the Delcath System in Patients With Ocular and Cutaneous Melanoma Metastatic to the Liver

Study identification

NCT ID
NCT01728051
Recruitment status
No Longer Available
Study type
Expanded access
Phase
Not listed
Lead sponsor
Delcath Systems Inc.
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • Melphalan Drug
  • Percutaneous Hepatic Perfusion Device

Drug · Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Oct 22, 2013

United States locations

U.S. sites
6
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
John Wayne Cancer Institute at Saint John's Health Center Santa Monica California 90404
Sky Ridge Medical Center Englewood Colorado 80112
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa Florida 33612-9497
University of Maryland Medical Center Baltimore Maryland 21201
Carol G. Simon Cancer Center at Morristown Memorial Hospital Morristown New Jersey 07962-1956
University of Pittsburg Cancer Institute Pittsburgh Pennsylvania 15232

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01728051, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 22, 2013 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01728051 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →